I commented on the Interims to December from AIM-listed Barkby Group (BARK) yesterday, noting a massive black hole in net current assets to the tune of a whopping £12.4 million. So how is the company paying for this acquisition – and the comprehensive refurbishment by June 2022?
AIM-listed Barkby Group (BARK) reported its interims to December 2021 yesterday morning. Having picked up on this outfit over Christmas, when it reported diabolical FY results to 1 July 2021 on Christmas Eve – an automatic Red Flag – was there any improvement this time?
AIM-listed Barkby Group (BARK) has announced the completion of a clinical study by Verso Biosense, a minority shareholding of the company. There were, natch, no numbers from this missive from a lookalike of the Adam Reynolds keyboard, so it is hardly an RNS released to inform shareholders…..but then, it is an RNS Reach.
